BiotechTube
Home/Vyluma/Houman Hemmati, MD, PhD
HH

Houman Hemmati, MD, PhD

Chief Medical Affairs Officer

Vyluma

Therapeutic Areas

OphthalmologyPediatric MyopiaRefractive Errors

Vyluma Pipeline

DrugIndicationPhase
NVK002Pediatric Myopia (progression)Phase 3
NVK029PresbyopiaPhase 2
NVK031Night Vision DisturbanceProof-of-Concept

Leadership Team at Vyluma

GZ
George Zorich
Chairman & CEO
TM
Tung M. Fong, PhD
Vice President, Clinical Development
View full Vyluma profile